Genetics of Parkinson's disease
- PMID: 10349506
- DOI: 10.1016/S0753-3322(99)80075-4
Genetics of Parkinson's disease
Abstract
Here we review familial Parkinson's disease from clinical, as well as molecular genetic aspects. To date, two genes responsible for familial Parkinson's disease have been identified: one is the alpha-synuclein gene located in the long arm of chromosome 4, and the other is the parkin gene located in the long arm of chromosome 6. The mode of inheritance of the former is autosomal dominant and clinical features consist of levodopa-responsive parkinsonism; the age of onset is younger than that of the sporadic cases (in their 40s), and the progression is faster (average disease duration approximately nine years). The latter form is transmitted as an autosomal recessive, and clinical features consist of early onset (in their 20s), levodopa-responsive parkinsonism, and a slow progression of the disease. In addition, the tau gene has been shown to be the disease gene for familial frontotemporal dementia and parkinsonism linked to chromosome 17. There are many other clinical phenotypes of familial Parkinson's disease among which three forms have been mapped to certain chromosome loci: one is in the short arm of chromosome 2, the two other forms are in the different loci of the short arm of chromosome 4. All of them are transmitted as autosomal dominant traits manifesting levodopa responsive parkinsonism. There still exists however, other clinical phenotypes of chromosome loci which are not known. Molecular cloning of these familial Parkinson's disease genes and the elucidation of the functions of the proteins encoded will certainly contribute greatly to the investigation of the etiology and pathogenesis of more common sporadic form of Parkinson's disease.
Similar articles
-
[A 73-year-old woman with familial Parkinson's disease].No To Shinkei. 1999 Dec;51(12):1087-96. No To Shinkei. 1999. PMID: 10654309 Japanese.
-
Importance of familial Parkinson's disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson's disease.J Neural Transm Suppl. 2000;(60):101-16. doi: 10.1007/978-3-7091-6301-6_6. J Neural Transm Suppl. 2000. PMID: 11205133 Review.
-
[Genetics of Parkinson disease].Rev Med Interne. 1999 Aug;20(8):709-14. doi: 10.1016/s0248-8663(99)80493-7. Rev Med Interne. 1999. PMID: 10480176 Review. French.
-
Genetics of Parkinson's disease.Ann N Y Acad Sci. 2000;920:28-32. doi: 10.1111/j.1749-6632.2000.tb06901.x. Ann N Y Acad Sci. 2000. PMID: 11193165 Review.
-
[Parkinson's disease: what have we learned from the genes responsible for familial forms?].Med Sci (Paris). 2003 May;19(5):613-9. doi: 10.1051/medsci/2003195613. Med Sci (Paris). 2003. PMID: 12836396 Review. French.
Cited by 7 articles
-
Fluctuation Imaging of LRRK2 Reveals that the G2019S Mutation Alters Spatial and Membrane Dynamics.Molecules. 2020 May 31;25(11):2561. doi: 10.3390/molecules25112561. Molecules. 2020. PMID: 32486414 Free PMC article.
-
Lessons on Differential Neuronal-Death-Vulnerability from Familial Cases of Parkinson's and Alzheimer's Diseases.Int J Mol Sci. 2019 Jul 4;20(13):3297. doi: 10.3390/ijms20133297. Int J Mol Sci. 2019. PMID: 31277513 Free PMC article. Review.
-
Genetics of parkin-linked disease.Hum Genet. 2004 Mar;114(4):327-36. doi: 10.1007/s00439-003-1074-6. Epub 2004 Jan 15. Hum Genet. 2004. PMID: 14727181 Review.
-
Environmental estrogen-like chemicals and hydroxyl radicals induced by MPTP in the striatum: a review.Neurochem Res. 2002 May;27(5):423-31. doi: 10.1023/a:1015556015299. Neurochem Res. 2002. PMID: 12064359 Review.
-
The aetiology of idiopathic Parkinson's disease.Mol Pathol. 2001 Dec;54(6):369-80. Mol Pathol. 2001. PMID: 11724911 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
